Literature DB >> 8223453

A defective human foamy provirus generated by pregenome splicing.

A Saïb1, J Périès, H de Thé.   

Abstract

Foamy viruses are a group of retroviruses of complex structure which were thought to be non-pathogenic. The recent demonstration of neurological diseases in mice transgenic for human foamy virus (HFV) and the high prevalence of HFV sequences in Graves' disease question this idea. By PCR, we have detected HFV sequences with a non-random deletion in the bel1 transactivator gene in other autoimmune conditions. Sequence analysis revealed that this deleted area corresponds to the excision of a known intron in bet, one of HFV's regulatory genes. The same phenomenon was observed in both acute and chronic infections, in vitro or in vivo, although the deleted forms were distinctly more abundant in chronic states. The viral DNA containing the bel1 deletion is apparently part of an otherwise complete genome, strongly suggesting that this provirus derives from the reverse transcription of a spliced pregenomic RNA. Bel1-spliced provirus was shown to be defective when transfected into permissive cells. However, co-expression with the Bel1 transactivator led to functional trans-complementation and formation of viral particles. Splicing of the genome may be an important factor in HFV biology: genomes with the deletion may either interfere with wild-type virus expression or alter host cell functions through background expression of viral regulatory proteins.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8223453      PMCID: PMC413743          DOI: 10.1002/j.1460-2075.1993.tb06129.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  28 in total

1.  Analysis of splicing patterns of human spumaretrovirus by polymerase chain reaction reveals complex RNA structures.

Authors:  W Muranyi; R M Flügel
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

2.  The LTR, v-src, LTR provirus generated in the mammalian genome by src mRNA reverse transcription and integration.

Authors:  J Bodor; J Svoboda
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

3.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

4.  Expression of a subgenomic retroviral messenger RNA.

Authors:  D W Stacey
Journal:  Cell       Date:  1980-10       Impact factor: 41.582

5.  Isolation of high-molecular-weight DNA from mammalian cells.

Authors:  M Gross-Bellard; P Oudet; P Chambon
Journal:  Eur J Biochem       Date:  1973-07-02

6.  Transacting transcriptional activation of human spumaretrovirus LTR in infected cells.

Authors:  A Rethwilm; K Mori; B Maurer; V ter Meulen
Journal:  Virology       Date:  1990-04       Impact factor: 3.616

7.  The 3'-orf protein of human immunodeficiency virus 2 shows sequence homology with the bel3 gene of the human spumaretrovirus.

Authors:  B Maurer; R M Flügel
Journal:  FEBS Lett       Date:  1987-10-05       Impact factor: 4.124

8.  Construction of an infectious DNA clone of the full-length human spumaretrovirus genome and mutagenesis of the bel 1 gene.

Authors:  M Löchelt; H Zentgraf; R M Flügel
Journal:  Virology       Date:  1991-09       Impact factor: 3.616

9.  A naturally occurring deletion mutant of figwort mosaic virus (caulimovirus) is generated by RNA splicing.

Authors:  H B Scholthof; F C Wu; R D Richins; R J Shepherd
Journal:  Virology       Date:  1991-09       Impact factor: 3.616

10.  Transactivation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by the human foamy virus bel1 protein requires a specific DNA sequence.

Authors:  A H Lee; K J Lee; S Kim; Y C Sung
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

View more
  26 in total

1.  A new retroelement constituted by a natural alternatively spliced RNA of murine replication-competent retroviruses.

Authors:  Laurent Houzet; Jean Luc Battini; Eric Bernard; Valerie Thibert; Marylène Mougel
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

2.  Characterization of a human foamy virus 170-kilodalton Env-Bet fusion protein generated by alternative splicing.

Authors:  D Lindemann; A Rethwilm
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 3.  Foamy viruses are unconventional retroviruses.

Authors:  M L Linial
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

4.  Reactivation of a complex retrovirus is controlled by a molecular switch and is inhibited by a viral protein.

Authors:  Christopher D Meiering; Maxine L Linial
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-01       Impact factor: 11.205

5.  Multiple integrations of human foamy virus in persistently infected human erythroleukemia cells.

Authors:  C D Meiering; K E Comstock; M L Linial
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

6.  Intra- and intercellular trafficking of the foamy virus auxiliary bet protein.

Authors:  Charles-Henri Lecellier; Wim Vermeulen; Françoise Bachelerie; Marie-Lou Giron; Ali Saïb
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

7.  Cell-type-specific regulation of the two foamy virus promoters.

Authors:  C D Meiering; C Rubio; C May; M L Linial
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

8.  An evolutionarily conserved splice generates a secreted env-Bet fusion protein during human foamy virus infection.

Authors:  M L Giron; H de Thé; A Saïb
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

9.  Complete genome sequences of two novel European clade bovine foamy viruses from Germany and Poland.

Authors:  Torsten Hechler; Magdalena Materniak; Timo Kehl; Jacek Kuzmak; Martin Löchelt
Journal:  J Virol       Date:  2012-10       Impact factor: 5.103

10.  Persistent infection with primate foamy virus type 1 increases human immunodeficiency virus type 1 cell binding via a Bet-independent mechanism.

Authors:  Cecile Schiffer; Charles-Henri Lecellier; Abdelkrim Mannioui; Nathalie Felix; Elisabeth Nelson; Jacqueline Lehmann-Che; Marie-Louise Giron; Jean Claude Gluckman; Ali Saib; Bruno Canque
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.